Lysophosphatidic acid synthesis and release

…, MF Simon, P Valet, JS Saulnier-Blache - Prostaglandins & other …, 2001 - Elsevier
Lysophosphatidic acid (LPA) is a bioactive phospholipid controlling numerous cellular
responses through the activation of specific G-protein coupled transmembrane receptors. LPA is …

Apelin, a newly identified adipokine up-regulated by insulin and obesity

…, C Carpéné, Y Audigier, JS Saulnier-Blache… - …, 2005 - academic.oup.com
The results presented herein demonstrate that apelin is expressed and secreted by both
human and mouse adipocytes. Apelin mRNA levels in isolated adipocytes are close to other …

Lysophosphatidic acid and renal fibrosis

…, D Salant, JL Bascands, JS Saulnier-Blache… - … et Biophysica Acta (BBA …, 2008 - Elsevier
The development of fibrosis involves a multitude of events and molecules. Until now the
majority of these molecules were found to be proteins or peptides. But recent data show …

Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis

…, K Tréguer, S Grès, C Attané, JS Saulnier-Blache - Biochimie, 2014 - Elsevier
… This is also observed after chronic treatment with Ki16425 (Rancoule and Saulnier-Blache,
personal results). Consequently, adipose tissue from FATX-KO mice and Ki16425-treated …

Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development

…, MJO Wakelam, JS Saulnier-Blache… - … and cellular biology, 2006 - Taylor & Francis
Autotaxin (ATX), or nucleotide pyrophosphatase-phosphodiesterase 2, is a secreted
lysophospholipase D that promotes cell migration, metastasis, and angiogenesis. ATX generates …

TNFα up‐regulates apelin expression in human and mouse adipose tissue

…, O Ziegler, C Carpene, JS Saulnier-Blache… - The FASEB …, 2006 - Wiley Online Library
We have recently identified apelin as a novel adipokine up‐regulated by insulin and obesity.
Since obesity and insulin resistance are associated with chronically elevated levels of both …

[HTML][HTML] Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer

…, CM Serre, S Grès, JS Saulnier-Blache… - The Journal of …, 2004 - Am Soc Clin Investig
The role of lysophosphatidic acid (LPA) in cancer is poorly understood. Here we provide
evidence for a role of LPA in the progression of breast cancer bone metastases. LPA receptors …

[HTML][HTML] Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation: up-regulated expression with …

…, P Valet, JA Boutin, JS Saulnier-Blache - Journal of Biological …, 2003 - ASBMB
… Jean Sébastien Saulnier-Blache Jean Sébastien Saulnier-BlacheSaulnier-Blache JS

[PDF][PDF] Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium

…, R Megens, K Heyll, J Chun, JS Saulnier-Blache… - Cell metabolism, 2011 - cell.com
Oxidatively modified low-density lipoprotein (oxLDL) plays a key role in the initiation of
atherosclerosis by increasing monocyte adhesion. The mechanism that is responsible for the …

[HTML][HTML] Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid

…, WH Moolenaar, P Valet, JS Saulnier-Blache - Journal of lipid …, 2011 - ASBMB
Autotaxin (ATX) is a secreted lysophospholipase D that generates the lipid mediator
lysophosphatidic acid (LPA). ATX is secreted by adipose tissue and its expression is enhanced in …